Feinsod Matthew 4
4 · APPLIED GENETIC TECHNOLOGIES CORP · Filed Jun 13, 2019
Insider Transaction Report
Form 4
Feinsod Matthew
Interim Chief Medical Officer
Transactions
- Award
Common Stock
2019-06-11+2,000→ 55,329 total - Tax Payment
Common Stock
2019-06-11$3.77/sh−685$2,582→ 54,644 total
Footnotes (1)
- [F1]The common stock vested immediately upon grant.